Integra LifeSciences reported a revenue increase of 4.3% on a reported basis and 8.3% on an organic basis for Q4 2021. GAAP earnings per diluted share were $0.53, while adjusted earnings per diluted share were $0.84, flat compared to Q4 2020.
Reported revenues increased by 4.3% on a reported basis and 8.3% on an organic basis compared to Q4 2020.
GAAP earnings per diluted share were $0.53, compared to $1.09 in Q4 2020.
Adjusted earnings per diluted share were $0.84, flat compared to Q4 2020.
Adjusted EBITDA for Q4 2021 was $105.4 million, compared to $102.7 million in Q4 2020.
The Company’s guidance for 2022 revenue and adjusted earnings per share reflects the continuing uncertainty around the scope and duration of the pandemic, and its related impacts on our business in the first half of the year.
Analyze how earnings announcements historically affect stock price performance